Results 281 to 290 of about 5,922,427 (309)
Some of the next articles are maybe not open access.
Alemtuzumab in Stem Cell Transplantation
Medical Oncology, 2002Alemtuzumab, otherwise called CAMPATH-1H, is a humanized monoclonal antibody directed against the CD52 antigen of lymphocytes. It is one of a family of CAMPATH-1 antibodies that have been used over the last 20 yr in stem cell transplantation for depletion of donor and recipient T-cells to prevent graft-versus-host disease and graft rejection.
openaire +2 more sources
Stem Cell Transplantation in Hemoglobinopathies
Hemoglobin, 2007beta-Thalassemia (thal) and sickle cell disease are the most common genetic diseases worldwide. Although supportive therapies such as regular transfusion and chelation for beta-thal and hydroxyurea (HU) for sickle cell disease have significantly improved clinical manifestations and the quality of life, they cannot eliminate disease and therapy-related ...
openaire +2 more sources
Hematopoietic stem cell transplantation
Current Opinion in Hematology, 2004Nonniekaye Shelburne +2 more
openaire +4 more sources
Hematopoietic stem cell transplantation
Current Opinion in Hematology, 1998openaire +2 more sources
The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer
Ca-A Cancer Journal for Clinicians, 1996Frederick Appelbaum
exaly
Stem cell transplantation for immunodeficiency
Springer Seminars in Immunopathology, 1998A, Fischer +6 more
openaire +2 more sources
Haematopoietic stem cell activity and interactions with the niche
Nature Reviews Molecular Cell Biology, 2019Sandra Pinho, Paul Frenette
exaly